Travilah Consulting Group
Overview
TCG Crossover, known as TCGX, is a healthcare and life sciences-focused investment firm that invests in both private and public companies. The firm focuses on innovative drug discovery companies and leverages a network of scientific advisors and operational executives to support its portfolio. TCGX employs a long-term, patient capital strategy through a closed-end fund structure. The firm was founded in 2021 by Dr. Chen Yu and has offices in Palo Alto and New York City.
Portfolio Companies
4
Website
tcgx.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LianBio | Oct 2020 | Series A | - |
| Mineralys Therapeutics | Feb 2024 | Private Placement | Co-investor |
| Cargo Therapeutics | Mar 2023 | Series A | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Travilah Consulting Group based?
Travilah Consulting Group is headquartered in Palo Alto, California, United States.
When was Travilah Consulting Group founded?
Founding year information for Travilah Consulting Group is not publicly available.
How many portfolio companies does Travilah Consulting Group have?
Travilah Consulting Group has 4 portfolio companies in Caplight's dataset.
What are some companies in Travilah Consulting Group's portfolio?
Portfolio companies visible on Caplight include LianBio, Mineralys Therapeutics, Cargo Therapeutics.
What was Travilah Consulting Group's most recent investment shown here?
Travilah Consulting Group's most recent investment in this portfolio sample was in Mineralys Therapeutics in 2024.
What sectors does Travilah Consulting Group focus on?
Travilah Consulting Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Travilah Consulting Group focus on?
Travilah Consulting Group typically invests at the Early stage.